# A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment

> **NCT02309671** · PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 159 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** FE 999049
- **DRUG:** follitropin beta

## Key facts

- **NCT ID:** NCT02309671
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-11
- **Final completion:** 2016-09
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2020-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02309671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02309671, "A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02309671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*